Journal of Neuropathology is categorized under Business Services (Unclassified) in Madison, WI and active since 2012.
Journal of Neuropathology was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Michael Hart at the company’s single location by writing to 1300 University Avenue, Madison, Wisconsin WI 53706 or by phoning (608) 265-4414. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Journal of Neuropathology |
Contact Person: | Michael Hart |
Address: | 1300 University Avenue, Madison, Wisconsin 53706 |
Phone Number: | (608) 265-4414 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Services (Unclassified) |
SIC Code: | 7389 |
NAICS Code: | 561499 |
Share This Business: |
Journal of Neuropathology was started in 2012 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael Hart for inquiries that concern Journal of Neuropathology by calling the company number (608) 265-4414, as your correspondence is most welcome. Additionally, the physical location of the single location of Journal of Neuropathology can be found at the coordinates 43.07338,-89.40734 as well as the street address 1300 University Avenue in Madison, Wisconsin 53706.
For its online presence, you may visit Journal of Neuropathology’s website at and engage with its social media outlets through on Twitter and on Facebook.